Lyell Immunopharma, Inc. (LYEL) vs Yarrow Bioscience, Inc (YARW)
Lyell Immunopharma, Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Lyell Immunopharma, Inc. and Yarrow Bioscience, Inc are of similar size ($248.0M and $246.0M). Yarrow Bioscience, Inc grew revenue faster over the last twelve months: 1.26% against −55.0%. Yarrow Bioscience, Inc has the higher net margin (−3,881.5% vs −920,285.2%) and the higher return on invested capital (0.00% vs −539.5%). Across the 16 metrics below, Yarrow Bioscience, Inc leads on 13 and Lyell Immunopharma, Inc. on 3.
Valuation
Profitability
| Metric | LYEL | YARW | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (949,981.48%) | (4,134.44%) | 0.00% |
| Net margin | (920,285.19%) | (3,881.54%) | 0.00% |
| Free cash flow margin | (647,681.48%) | (3,513.07%) | 0.00% |
| Return on equity | (93.28%) | (61.40%) | (57.72%) |
| Return on assets | (71.34%) | (54.77%) | (49.22%) |
| Return on invested capital | (539.53%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack